Overcoming Barriers to the Initiation of Long-Acting Insulin Therapy for Diabetes Management

Overcoming Barriers to the Initiation of Long-Acting Insulin Therapy for Diabetes Management

On-Demand Webcast
Faculty

Luigi Meneghini, MD
Professor, Internal Medicine
UT Southwestern Medical Center
Executive Director, Global Diabetes Program
Parkland Hospital Health System
Dallas, Texas

Intended Learners

This activity is designed for primary care physicians, general practitioners, family medicine specialists, internists, pediatricians, nurse practitioners, nurses, physician assistants, pharmacists, registered dietitians, certified diabetes educators, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify barriers to early insulin initiation and consequences of delayed insulin treatment
  • Describe the goals of long-acting basal insulin therapy
  • Assess the known safety, efficacy, and use in combination therapy of long-acting basal insulin
  • Implement tailored treatment plans to reflect guideline recommendations and address treatment adherence
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: November 22, 2017

Expiration Date: November 22, 2018

Estimated time to complete: 30 minutes

Participants who completed the live version of this activity are not eligible to receive credit for this enduring material.

ACPE Credit Policy

Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, NACCME will not be able to report your activity completion to CPE Monitor after this 60-day period.

For questions regarding this educational activity, please call 609-371-1137, ext. 6219.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

  In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Save

CME

NACCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

CNE

This continuing nursing education activity awards 0.50 contact hour.

This continuing nursing activity awards up to 0.375 pharmacology credits.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credit™ through its reciprocity agreements.

CPE for Pharmacists

This activity is approved for 0.50 contact hour (0.05 CEU) of continuing pharmacy education: 0276-0000-17-062-HO1-P

This educational activity is a knowledge-based activity. 

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, Suite 200, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

CPE for Dietitians

North American Center for Continuing Medical Education, LLC (NACCME) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 0.5 Continuing Professional Education unit (CPEU) for completion of this activity/material.  CDR Activity Number: 137433. Provider Number: HM001, Level 3.

Save

Save

Save

Save

Planning Committee

The planning committee is comprised of Luigi Meneghini, MD; Lorena Alarcon Casas Wright, MD, Susie Seaman, NP, Donna Brophy, MaryEllen Fama, Mary Johnson, Randy Robbin, John Savage, NACCME.

Independent Clinical Reviewer:

Lorena Alarcon Casas Wright, MD
Clinical Associate Professor
University of Washington School of Medicine/Endocrinology
University of Washington Medical Center/Roosevelt
Seattle, Washington

Nurse Planner:

Susie Seaman, NP
Sharp Rees-Stealy Wound Clinic
San Diego, California

Financial Disclosures and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Meneghini: Consultant–Aventis, Merck, Novo Nordisk, Sanofi; Grant/Research Support–American Diabetes Association

Ms. Seaman: Advisory Board – MoInlycke Health Care

Dr. Wright has disclosed no relevant financial relationships with any commercial interests.

Ms. Brophy, Ms. Fama, Ms. Johnson, Mr. Robbin, Mr. Savage (NACCME) have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering

Provided by North American Center for Continuing Medical Education, LLC, An HMP Company.

Grant Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC and an educational grant from Novo Nordisk, Inc.